Skip to main content
# Title Department Research Member Research Year
531 Tri-modalities for bladder cancer in elderly: Trans-urethral resection, hypofractionated radiotherapy and gemcitabine Department of Surgical Oncology Prof. Mohammed Aboul-Magd Salem Mahmoud 2018
532 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2018
533 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2018
534 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Department of Pediatric Oncology Dr. Khaled Fathy Riad Osman 2018
535 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2018
536 Tri-modalities for bladder cancer in elderly: Trans-urethral resection, hypofractionated radiotherapy and gemcitabine Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2018
537 Delayed diagnosis of contralateral tension pneumothorax during robotic lung wedge resection‏ Department of Anesthesia, Intensive care and Pain management Ahmed ahmed ibrahem ahmed 2018
538 Preoperative Conformal Radiotherapy Concurrently with Paclitaxel/Carboplatin in Gastric Cancer Department of Surgical Oncology Dr. Khalid Mohammed Rizk Saleh 2018
539 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2018
540 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
Department of Radiotherapy and Nuclear medicine Dr. Mona Mahmoud Sayed 2018